Supplementary Figures – Adjuvant EGFR tyrosine kinase inhibitors forpatients with resectedEGFR-mutatednon-small-cell lung cancer: a networkmeta-analysis

Figure 1: Risk classification

Figure 2: Brooks–Gelmandiagnoses of astringency 

Figure 3: Heterogeneity results of head-to-head comparisons in forest plots according to feasible pairwise, back-calculatedand network 

Figure 4: Sensitivity analysis